CJ Bioscience, Inc. (KOSDAQ:311690)
9,300.00
+50.00 (0.54%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Microbiological Analysis | 2.98B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Microbiological Analysis Growth | -29.33% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| DB Provided | 331.54M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| DB Provided Growth | 32.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Intestinal Microbiota Monitoring, Etc. | 155.45M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Intestinal Microbiota Monitoring, Etc. Growth | -27.70% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Real Estate Rental | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Real Estate Rental Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Microbial Analysis Equipment | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Microbial Analysis Equipment Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| South Korea | 3.00B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | -27.69% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International | 464.75M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International Growth | -12.18% |
Log In |
Log In |
Log In |
Log In | Upgrade
|